Dissolution Science: Complex Drug Products

The Society of Pharmaceutical Dissolution Science – US Chapter (SPDS-US Chapter),

established in 2019 as a non-profit entity, aims to propel the advancement of Dissolution

Science and Technology globally among professionals in the pharmaceutical sector,

regulatory bodies, and academic institutions. Dissolution Science is undergoing rapid

transformations, at a pace unparalleled in recent decades. In response to this swift

evolution, disseminating newly acquired knowledge has emerged as a paramount

objective of the Chapter. This dissemination is achieved through the organization of

scientific webinars, conferences, and workshops.

The forthcoming in-person conference, titled "Dissolution Science: Complex Drug

Products," is set to explore a wide range of topics pertaining to the dissolution challenges

encountered with complex drug products. The conference aims to equip participants with

a comprehensive understanding of:

• Predictive dissolution for complex drug products.
• The intricacies involved in the dissolution/drug release testing of oral complex
• dosage forms and long-acting injectables.
• The regulatory dimensions associated with dissolution methodologies.

This meticulous focus on the dissolution aspect of drug development highlights the

critical role this field plays in the pharmaceutical industry, emphasizing the importance of

keeping abreast with the latest scientific and regulatory advancements.

Featured Speakers:

• GSK
• National University of Singapore
• Gilead
• University of Toronto
• Merck
• Pfizer
• US FDA
• Institute of Chemical Technology
• AbbVie
• University of Copenhagen
• Catalent
• University of Bath
• Lonza
• ... and more